 |
|
Molecular Basis of Drug Resistance: Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and Anaplastic Lymphoma Kinase Inhibitors
Sei-Hoon Yang
Tuberc Respir Dis. 2013;75(5):188-198. Published online 2013 Nov 29 DOI: https://doi.org/10.4046/trd.2013.75.5.188
|
|
Citations to this article as recorded by
 Cucurbitacin E Exerts Anti-Proliferative Activity via Promoting p62-Dependent Apoptosis in Human Non-Small-Cell Lung Cancer A549 Cells
Han-Lin Hsu, Bo-Jyun Lin, Yu-Chen Lin, Chih-Chieh Tu, Nham-Linh Nguyen, Ching-Chiung Wang, Mei-Chuan Chen, Chun-Han Chen
Current Issues in Molecular Biology.2023; 45(10): 8138. CrossRef Inhibition of mitochondrial glutaminase activity reverses acquired erlotinib resistance in non-small cell lung cancer
Caifeng Xie, Jiangbo Jin, Xujie Bao, Wei-Hua Zhan, Tian-Yu Han, Mingxi Gan, Chengfu Zhang, Jianbin Wang
Oncotarget.2016; 7(1): 610. CrossRef The Frequency of EGFR Mutation in Lung Adenocarcinoma and the Efficacy of Tyrosine Kinase Inhibitor Therapy in a Hungarian Cohort of Patients
Veronika Sárosi, Zoltán Balikó, Gábor Smuk, Terézia László, Mariann Szabó, István Ruzsics, Emese Mezősi
Pathology & Oncology Research.2016; 22(4): 755. CrossRef EGFR mediates docetaxel resistance in human castration-resistant prostate cancer through the Akt-dependent expression of ABCB1 (MDR1)
Tzyh-Chyuan Hour, Shiu-Dong Chung, Wang-Yi Kang, Ying-Chu Lin, Shu-Ju Chuang, A-Mei Huang, Wen-Jeng Wu, Shu-Pin Huang, Chao-Yuan Huang, Yeong-Shiau Pu
Archives of Toxicology.2015; 89(4): 591. CrossRef Targeting protein–protein interactions in hematologic malignancies: still a challenge or a great opportunity for future therapies?
Tomasz Cierpicki, Jolanta Grembecka
Immunological Reviews.2015; 263(1): 279. CrossRef Decreased expression of nucleophosmin/B23 increases drug sensitivity of adriamycin-resistant Molt-4 leukemia cells through mdr-1 regulation and Akt/mTOR signaling
Lingyan Wang, Buyuan Chen, Minhui Lin, Yanqin Cao, Yingyu Chen, Xinji Chen, Tingbo Liu, Jianda Hu
Immunobiology.2015; 220(3): 331. CrossRef Current and future targeted therapies for non-small-cell lung cancers with aberrant EGF receptors
Shanthi Kanthala, Sandeep Pallerla, Seetharama Jois
Future Oncology.2015; 11(5): 865. CrossRef Registered report: Widespread potential for growth factor-driven resistance to anticancer kinase inhibitors
Edward Greenfield, Erin Griner
eLife.2014;[Epub] CrossRef Personalized medicine in hematology — A landmark from bench to bed
Gayane Badalian-Very
Computational and Structural Biotechnology Journal.2014; 10(17): 70. CrossRef
|